Airway remodeling (AR) is a progressive pathological feature from the obstructive lung illnesses, including asthma and chronic obstructive pulmonary disease (COPD). guarantee for deterring or dealing with AR. The function of prostaglandin E 2 (PGE 2) and E-prostanoid (EP) receptor subtypes in mitigating AR is a subject matter of recent analysis. Early studies showed that… Continue reading Airway remodeling (AR) is a progressive pathological feature from the obstructive